VIALASE
ViaLase develops an image-guided femtosecond laser surgical system for the treatment of glaucoma. The company's system focuses on the development of micron-resolution OCT image-guided femtosecond laser technology to create micron-sized customized drainage channels through the trabecular meshwork that connects the anterior chamber to the Schlemm's canal without surgically opening or penetrating the eye, enabling medical professionals to improve glaucoma management with its efficient non-invasive treatment. ViaLase was incorporated in 2019 and is headquartered in Corona Del Mar, California.
VIALASE
Industry:
Health Care Medical Device Wellness
Founded:
2019-01-01
Address:
Corona Del Mar, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
949-538-6623
Total Funding:
35.43 M USD
Similar Organizations
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Fitternity
India's largest online fitness platform that provides an integrated eco-system to help users start & sustain their fitness journey.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
metaMe Health
MetaMe Health develops FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Current Employees Featured
Founder
Investors List
Arboretum Ventures
Arboretum Ventures investment in Series A - ViaLase
Venture Investors
Venture Investors investment in Series A - ViaLase
Versant Ventures
Versant Ventures investment in Series A - ViaLase